help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 25, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2509
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/6/2402    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishimoto, H.
Right arrow Articles by Jaffe, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishimoto, H.
Right arrow Articles by Jaffe, R. B.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology

Submitted on November 12, 2007
Accepted on March 17, 2008

The Periphery of the Human Fetal Adrenal Gland Is a Site of Angiogenesis: Zonal Differential Expression and Regulation of Angiogenic Factors

Hitoshi Ishimoto, Kazuhiro Minegishi, Takayuki Higuchi, Masataka Furuya, Satoshi Asai, Seon Hye Kim, Mamoru Tanaka, Yasunori Yoshimura, and Robert B. Jaffe*

Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan 160-8582, and Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143-0556

* To whom correspondence should be addressed. E-mail: jaffer{at}obgyn.ucsf.edu.

CONTEXT: While the inner fetal zone (FZ) of the midgestation human fetal adrenal (HFA) produces dehydroepiandrosterone sulfate, the function of the outer definitive zone (DZ) remains less clear. We have proposed that the DZ phenotype is that of a pool of progenitor cells, many of which are mitotically active. Recently we studied HFA expression of a family of vascular endothelial cell-specific angiogenic factors, the angiopoietins (Angs), and demonstrated that Ang2 was localized predominantly in the periphery of the gland. Ang1 stabilizes, while Ang2 destabilizes, vessels, increasing responsiveness to angiogenic stimuli such as vascular endothelial growth factor-A (VEGF-A) and fibroblast growth factor-2 (FGF-2).

OBJECTIVE: To test the hypothesis that the periphery of the HFA is a site of angiogenesis.

DESIGN: Studies were conducted involving RNA, frozen sections, and primary cell cultures from midgestation HFAs.

MAIN OUTCOME MEASURES: Immunofluorescence, laser-capture microdissection and real-time quantitative RT-PCR were used.

RESULTS: Double immunostaining demonstrated that proliferating endothelial cells were limited to the DZ and DZ/FZ border. Ang2 mRNA was primarily expressed in the DZ whereas Ang1 mRNA was primarily in the FZ. VEGF-A and FGF-2 mRNA levels were higher in the DZ. FGF-2 (10 ng/ml) induced Ang2 mRNA by 4-fold in both zones of cells (P < 0.01, at 24 h), but not Ang1 nor VEGF-A mRNA.

CONCLUSIONS: Data suggest that angiogenesis occurs at the periphery of the HFA. The DZ-predominant expression of Ang2 may be explained, in part, by the parallel pattern of FGF-2 expression.


Key words: Adrenal • Fetus • Angiopoietin • Angiogenesis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society